{"id":15905,"date":"2021-06-21T20:05:25","date_gmt":"2021-06-21T14:35:25","guid":{"rendered":"https:\/\/cigniti.com\/blog\/?p=15905"},"modified":"2021-12-29T14:53:15","modified_gmt":"2021-12-29T09:23:15","slug":"artificial-intelligence-ai-pharmaceutical","status":"publish","type":"post","link":"https:\/\/www.cigniti.com\/blog\/artificial-intelligence-ai-pharmaceutical\/","title":{"rendered":"AI is here to stay. It’s time the Pharma industry woke up to it"},"content":{"rendered":"
When discussing the future of any industry, it is difficult to avoid mentioning Artificial Intelligence (AI).<\/span>\u00a0<\/span><\/p>\n AI has revolutionized how scientists discover new treatments, combat diseases, and more in the pharmaceutical and biotech industries in the last five years.<\/span>\u00a0<\/span><\/p>\n To help deliver safe, reliable pharmaceuticals to the market, the pharmaceutical industry has traditionally depended on cutting-edge technologies.<\/span>\u00a0<\/span><\/p>\n AI is a term used in the pharmaceutical industry to describe the use of automated algorithms to do tasks that previously required human intelligence.<\/span>\u00a0<\/span><\/p>\n With the latest outbreak, pharmaceutical companies are under more pressure than ever to produce treatments and vaccines to market as soon as possible.<\/span>\u00a0<\/span><\/p>\n According to\u00a0<\/span>Gartner<\/span><\/i><\/b>, \u201c<\/span>As far as enterprise artificial intelligence projects are concerned, the COVID-19 pandemic was just a minor bump in the road.\u00a024% of business and IT professionals surveyed said they increased AI investment during the pandemic, and 42% kept investment at the same level.\u00a0Driving current AI investment has been customer experience and retention, revenue growth, and cost optimization.\u00a0Those areas of focus are likely to continue as new projects are initiated in the post-pandemic business world, which will be rich with AI investment<\/span><\/i><\/b>.\u201d<\/span>\u00a0<\/span><\/p>\n In the pharmaceutical and\u00a0customer\u00a0healthcare\u00a0businesses, AI and machine learning\u00a0(ML)\u00a0have proven\u00a0to be\u00a0crucial.<\/span>\u00a0<\/span><\/p>\n COVID and the race to\u00a0discover\u00a0viable vaccines are\u00a0fostering\u00a0the use of AI and ML\u00a0in this pandemic.<\/span>\u00a0<\/span><\/p>\n The following are the top-level usages\u00a0in the pharmaceutical and consumer healthcare\u00a0businesses:<\/span>\u00a0<\/span><\/p>\n We\u00a0see AI\u00a0and\u00a0ML being used in a variety of areas for\u00a0pharmaceutical\u00a0and\u00a0healthcare firms, including\u00a0Supply Chain, Customer Service,\u00a0Martech, AdTech,\u00a0and sales.<\/span>\u00a0<\/span><\/p>\n While the top-level usage of AI in the pharma industry is huge, larger establishments face a few challenges while adopting AI.<\/span>\u00a0<\/span><\/p>\n The following are some of the major obstacles to AI adoption in larger\u00a0organizations:<\/span>\u00a0<\/span><\/p>\n Data Challenges<\/span><\/b>\u00a0– Data quantity and quality\u00a0–\u00a0A training data set containing a minimum of 2 to 3 years of historical data is required for every machine learning model to perform effectively. Due to mergers and acquisitions, prior data management, or the lack of a prior source of data, this is the most crucial difficulty we find in large enterprises.<\/span>\u00a0<\/span><\/p>\n Challenges with Skills<\/span><\/b>\u00a0– Finding the correct resource with the right background might be difficult. We have a limited pool of data science experts in the market, which causes delays in hiring and training them to grow many AI initiatives.<\/span>\u00a0<\/span><\/p>\n According to\u00a0<\/span>Erick\u00a0Brethenoux<\/span><\/i><\/b>, research vice president at\u00a0<\/span>Gartner<\/span><\/i><\/b>,\u00a0“<\/span>The biggest misconception in the journey to successfully scaling AI is the search for ‘unicorns,’ or the perfect combination of AI, business and IT skills all present in a single resource. Since this is impossible to fulfill, focus instead on bringing together a balanced combination of such skills to ensure results<\/span><\/i><\/b>.\u00a0<\/span>AI talent is multiple things, and business professionals, whether they consider themselves at risk for AI-driven obsolescence or not, should consider training in some way that makes them valuable for a future of automated work<\/span><\/i><\/b>.\u201d<\/span>\u00a0<\/span><\/p>\n Commercial\u00a0Value<\/span><\/b>\u00a0– Larger companies are having difficulty demonstrating the business value of AI\u00a0programs. We’d like to deploy more cognitive services based on chatbots, for example. Adaptability, on the other hand, is insignificant, making it difficult to demonstrate the worth of such\u00a0endeavors.<\/span>\u00a0<\/span><\/p>\n Explainability<\/span><\/b>\u00a0–\u00a0Many “black box” models result in a conclusion, such as a forecast, but no explanation. You’re not likely to challenge the system’s conclusion if it coincides with what you already know and believe is correct. But what if you have a disagreement? You’re curious as to how the choice was reached. In many circumstances, just making a decision isn’t enough. When it comes to their patients’ health, doctors cannot rely only on the system’s recommendations.<\/span>\u00a0<\/span><\/p>\n Local interpretable model-agnostic explanations\u00a0(LIME)\u00a0is\u00a0one method for increasing model transparency.\u00a0<\/span>\u00a0<\/span><\/p>\n If AI determines that a patient has the flu, it will also reveal which data points were used to make that determination: sneezing and headaches, but not the patient’s age or weight, for example.\u00a0<\/span>\u00a0<\/span><\/p>\n When we’re provided the reasoning behind a conclusion, it’s much easier to determine how much we can trust the model.<\/span>\u00a0<\/span><\/p>\n The application of AI allows pharmacists to play a more active role in patient care, which is critical as value-based care models continue to dominate the health-care industry.\u00a0<\/span>\u00a0<\/span><\/p>\n Managing medicine inventories can be overwhelming for pharmacists.<\/span>\u00a0<\/span><\/p>\n According to\u00a0<\/span>McKinsey<\/span><\/i><\/b>, \u201c<\/span>Artificial intelligence is here to stay. Machine Learning and Big Data in the pharmacy and medical space might be worth $100 billion each year. Although some remain wary of AI’s promise, it’s evident that the pharmaceutical business is uniquely positioned to benefit and grow as a result of its implementation<\/span><\/i><\/b>.\u201d<\/span>\u00a0<\/span><\/p>\n Despite the fact that pharmacists are highly trained\u00a0in patient\u00a0care, they are frequently forced to function as de facto supply chain experts in order to keep their hospitals\u00a0stocked with the pharmaceuticals\u00a0they require.\u00a0<\/span>\u00a0<\/span><\/p>\n Pharmacists can focus their efforts on patient care with the use of artificial intelligence, as some states have\u00a0recognized\u00a0in an official capacity.<\/span>\u00a0<\/span><\/p>\n While leveraging AI for testing apps for quality, enterprises may face multiple challenges,\u00a0such as identifying the exact use cases, lack of awareness about what really needs to be done, verifying the app\u2019s\u00a0behavior based on the data that has been input, testing apps for functionality, performance, scalability, security, & more.\u00a0<\/span>\u00a0<\/span><\/p>\n Cigniti\u2019s\u00a0extensive experience in the use of AI, ML, & analytics helps enterprises improve their automation frameworks & QA practices.\u00a0Cigniti\u00a0provides AI\/ML-led testing<\/a> and performance engineering services<\/a> for your QA framework through implementation of its next gen IP, BlueSwan<\/a>™.<\/span>\u00a0<\/span><\/p>\n With a strong focus on AI algorithms for test suite optimization, defect analytics, customer sentiment analytics<\/a>, scenario traceability, integrated requirements traceability matrix (RTM), rapid impact analysis, comprehensive documentation and log analytics, at\u00a0Cigniti, we have established a 4-pronged AI-led testing approach that includes:<\/span>\u00a0<\/span><\/p>\n Use our expertise in defect predictive analytics and test execution to ensure 100% test coverage for your AI-based applications.<\/span>\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":" When discussing the future of any industry, it is difficult to avoid mentioning Artificial Intelligence (AI).\u00a0 AI has revolutionized how scientists discover new treatments, combat diseases, and more in the pharmaceutical and biotech industries in the last five years.\u00a0 To help deliver safe, reliable pharmaceuticals to the market, the pharmaceutical industry has traditionally depended on […]<\/p>\n","protected":false},"author":20,"featured_media":15906,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"footnotes":""},"categories":[2173],"tags":[3602,2475,3603,3599,3601,3600,1149,3598],"ppma_author":[3727],"class_list":["post-15905","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence","tag-ai-at-larger-enterprises","tag-ai-for-testing-apps","tag-ai-in-pharma-industry","tag-ai-testing","tag-ai-led-testing-approach","tag-ai-ml-led-testing","tag-healthcare-software-testing","tag-pharmaceutical-testing"],"authors":[{"term_id":3727,"user_id":20,"is_guest":0,"slug":"cigniti","display_name":"About Cigniti (A Coforge Company)","avatar_url":{"url":"https:\/\/www.cigniti.com\/blog\/wp-content\/uploads\/2024\/10\/Coforge-blog-Logo.png","url2x":"https:\/\/www.cigniti.com\/blog\/wp-content\/uploads\/2024\/10\/Coforge-blog-Logo.png"},"user_url":"https:\/\/www.cigniti.com\/","last_name":"(A Coforge Company)","first_name":"About Cigniti","job_title":"","description":"Cigniti Technologies Limited, a Coforge company, is the world\u2019s leading AI & IP-led Digital Assurance and Digital Engineering services provider. Headquartered in Hyderabad, India, Cigniti\u2019s 4200+ employees help Fortune 500 & Global 2000 enterprises across 25 countries accelerate their digital transformation journey across various stages of digital adoption and help them achieve market leadership by providing transformation services leveraging IP & platform-led innovation with expertise across multiple verticals and domains.\r\nTop-Level usage in the pharmaceutical and consumer healthcare industries\u00a0<\/strong><\/h4>\n
\n
\n
Challenges in adopting AI at larger enterprises\u00a0<\/strong><\/h4>\n
Changing the Pharmacy Industry’s Future\u00a0<\/strong><\/h4>\n
Conclusion\u00a0<\/strong><\/h4>\n
\n
\r\nLearn more about Cigniti at www.cigniti.com<\/a> and about Coforge at www.coforge.com<\/a>."}],"_links":{"self":[{"href":"https:\/\/www.cigniti.com\/blog\/wp-json\/wp\/v2\/posts\/15905"}],"collection":[{"href":"https:\/\/www.cigniti.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cigniti.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cigniti.com\/blog\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cigniti.com\/blog\/wp-json\/wp\/v2\/comments?post=15905"}],"version-history":[{"count":0,"href":"https:\/\/www.cigniti.com\/blog\/wp-json\/wp\/v2\/posts\/15905\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cigniti.com\/blog\/wp-json\/wp\/v2\/media\/15906"}],"wp:attachment":[{"href":"https:\/\/www.cigniti.com\/blog\/wp-json\/wp\/v2\/media?parent=15905"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cigniti.com\/blog\/wp-json\/wp\/v2\/categories?post=15905"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cigniti.com\/blog\/wp-json\/wp\/v2\/tags?post=15905"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.cigniti.com\/blog\/wp-json\/wp\/v2\/ppma_author?post=15905"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}